The Emergency Nobody Rehearses
Ask an injector what they would do if a patient lost vision during a treatment, and you will usually get a protocol. Ask when they last rehearsed it, and the answer changes.
This is the complication that sits at the far end of every consent form and almost never appears in a portfolio. It is rare enough that most practitioners will finish a career without seeing one, and severe enough that the ones who do see it remember the room. Both of those facts are load-bearing, and they pull in opposite directions.
What follows is not a treatment protocol. It is an account of what the reported cases share, what the timing evidence actually says, and why the part of the response that matters most is the part you arrange before the appointment rather than during it.
The eye is downstream of the face
The mechanism is embolic and retrograde. Filler introduced under pressure into a facial artery can travel against normal flow, reach the ophthalmic circulation through connections that exist in every face, and lodge in the retinal or posterior ciliary supply. The anastomoses that make this possible are not anomalies. They are ordinary anatomy, which is why the danger is a property of the region rather than of an unlucky patient.
The reviews of the world literature are consistent about where it happens. The glabella, the nose and the nasolabial region account for the majority of reported cases, with the forehead and periorbital area behind them [1]. A systematic review of case reports and series found the same clustering, and noted that most patients presented with immediate visual symptoms rather than delayed ones [2]. That immediacy is the only real advantage the practitioner has — and it is easy to waste.
The earlier review of the same literature is worth reading beside the update rather than instead of it, because the case count grew substantially between them without the pattern changing [6]. That is a useful signal. When a body of case reports triples and the regions, the presentations and the outcomes stay where they were, the finding is probably about the anatomy rather than about who happened to report.
The window is not the one in the consultation
The reason speed matters is not clinical folklore. Work on retinal tolerance in central retinal artery occlusion — done long before anyone was injecting fillers for cosmetic reasons — established that the retina survives complete arterial obstruction for a period measured in a small number of hours, with irreversible damage accumulating well inside that span [3]. The occlusion in question there was experimental and complete, and a filler embolus is neither of those things reliably, so the figure should be read as an order of magnitude rather than a deadline you can work to.
Read that carefully, because it is doing a lot of work. It does not tell you that treatment inside the window restores vision. It tells you that outside it, nothing will. The distinction matters because the reported outcomes are poor even when the response was fast, and a protocol that promises recovery is selling something the literature does not support [1][2].
What the reported cases have in common
Three features recur often enough to be worth planning around. The first is that the patient usually knows immediately — pain, visual change, or both, at the moment of injection or within seconds of it. The second is that the practitioner frequently does not act on what the patient has said for several minutes, because the first instinct is to look at the skin rather than to believe the report. The third is that the referral, when it happens, goes to a general emergency department rather than to ophthalmology — and arrives without the one piece of information that changes the receiving clinician's assessment: what was injected, where, and when.
None of that is a technical failure. It is a coordination failure, and coordination failures are the kind you can fix on a quiet afternoon rather than in the moment.
There is a fourth feature, harder to write about because it does not appear in a case report. The practitioner is, at that moment, the person who caused the injury — and the reflex to establish that it cannot be happening is strong, human, and expensive. Every minute spent confirming that the patient is mistaken is a minute spent inside a window that is closing. This next part is reasoning rather than a sourced finding, but it is the reason a written pathway outperforms a knowledgeable clinician: the pathway does not need to believe anything before it acts.
What the evidence does not settle
Retrobulbar hyaluronidase is where the literature becomes genuinely contested, and it is worth being honest about that rather than picking a side. A case series reported visual improvement in some patients after retrobulbar injection following hyaluronic acid embolisation [4]. The commentary published alongside it argued that the anatomical and pharmacological case for the enzyme reaching and dissolving an intraluminal embolus is weak, that spontaneous partial recovery confounds any uncontrolled series, and that the reported successes may not be attributable to the intervention at all [5].
Both of those papers are in the same journal, a few months apart, and neither has been settled by anything published since. What follows from that is narrower than it looks: an intervention with a contested mechanism, a difficult injection technique and no controlled evidence is not a procedure to be attempted for the first time in an aesthetic clinic, on a patient who is losing sight, by someone who has read about it. It is a procedure for people who perform retrobulbar injections routinely. That is an argument about who — not an argument about whether.
The wider caveat applies to everything above. This is a literature of case reports and small series, which means it records what was noticed and written up, not what happened. Under-reporting is near-certain in a field where the injector is often the sole clinician involved and has an obvious reason not to publish. Prevalence figures drawn from it should be read as a floor, and any confident statement about how often this occurs — in either direction — is running ahead of what case reports can support.
Preparation is the part that is actually yours
Name the receiving service before you need it. Find out which hospital in your area takes acute ophthalmic emergencies out of hours, whether they expect a call first, and what number reaches a registrar rather than a switchboard. Write it where the person making the call can read it while doing something else.
Decide who makes the call. In a single-handed clinic the injector is also the person on the telephone, the person reassuring the patient and the person finding the notes. That does not work. If you practise alone, the plan has to say what gets dropped.
Write the handover before the day. The receiving clinician needs the product, the site, the time of injection and the time symptoms began. A pre-written form that someone fills in as it happens outperforms recall under pressure, and it survives the transfer in a way a verbal account does not.
Treat the patient's report as the finding. A patient who says they cannot see properly has given you a symptom that outranks anything you can observe on the skin. Acting on it and being wrong costs an unnecessary referral. Waiting to confirm it costs the only thing that is not recoverable.
Rehearse it out loud, once. Not a scenario day. A conversation with whoever is in the building about who does what, run through in the time it takes to make coffee. Almost nobody does this, and it is the single cheapest thing on the list.
Why this belongs in a training decision
A course that covers this subject in a slide is not covering it. The thing being taught is not a technique — it is a sequence of decisions made under time pressure by someone who has never made them before, and that is taught by rehearsal and by proximity to people who have managed it, not by a diagram of the ophthalmic artery.
Ask a provider what happens in their teaching when the simulated patient says they cannot see. If the answer is a protocol on a handout, you have learned something about the course. The practitioners who handle this well are not the ones who memorised the anatomy. They are the ones who had already decided, on an ordinary afternoon, who was going to pick up the telephone.
Browse aesthetic medicine courses